�鶹Ů��

And she is pressing the Republican presidential candidates to speak out on the matter. “I am deeply concerned by how this could harm Medicare beneficiaries,” Mrs. Clinton said in a statement. “This is outrageous and senseless, and Congress must act to fix the law. I support efforts by the Obama administration and Democratic leaders in Congress to try to resolve this quickly. At a time when out-of-pocket medical costs are already rising, we cannot afford to let Republican obstructionism pile additional costs on our seniors. I urge the Republican candidates for president to call on their congressional majority to end the games and protect our seniors.” The statement from Mrs. Clinton came as the Obama administration is urging Congress to adjust the increase in health insurance premium increases, which could affect almost a third of Medicare beneficiaries. Discussions [are] taking place among leaders in Congress to resolve the problem, but there is a concern that House Republicans may not be persuaded to address it. (Haberman, 10/16)

Democratic presidential candidate Hillary Clinton on Friday urged Congress to rein in Medicare cost increases next year, expected to hit millions on the government health insurance program even as Social Security benefits stagnate. Medicare expects Part B premiums, which cover doctor's visits and outpatient care, to rise 52 percent next year, which could hit around 16.5 million people. At the same time, a lack of inflation will keep beneficiaries of Social Security from getting an increase in the amount they receive each month. (Lopez, 10/16)

Hillary Rodham Clinton is urging Congress to fix an "outrageous and senseless" expected increase in Medicare deductibles and premiums. Clinton says she is "deeply concerned" by news that there will be no cost-of-living increase in Social Security benefits next year. As a result, some Medicare bills are set to increase for many, unless Congress acts to prevent it. (Thomas, 10/16)

Democratic presidential frontrunner Hillary Clinton has received more campaign cash from drug companies than any candidate in either party, even as she proudly declares the industry is one of her biggest enemies. Clinton accepted $164,315 in the first six months of the campaign from drug companies, far more than the rest of the 2016 field, according to an analysis by Stat News. (Ferris, 10/17)

Sen. Bernie Sanders (I-Vt.) declined to accept a maximum campaign donation from the CEO of a company that increased the price of a drug used by HIV and AIDS patients by hundreds of dollars, choosing instead to donate the money to a Washington health clinic. (Levine, 10/17)

Republican presidential contender Marco Rubio blasted pharmaceutical company “profiteering” on high-cost prescription drugs during a campaign stop this week — a sign that drug prices are becoming a lightning rod for both parties in the election. (Norman, 10/16)

When Turing Pharmaceuticals raised the price of an older generic drug by more than 5,000 percent last month, the move sparked a public outcry. How, critics wondered, could a firm charge $13.50 a pill for a treatment for a parasitic infection one day and $750 the next? The criticism led Turing’s unapologetic CEO to say he’d pare back the increase – although no new price has yet been named – and the New York attorney general has launched an antitrust investigation. The outcry has again focused attention on how drug prices are set in the United States. Aside from some limited government control in the veterans health care system and Medicaid, prices are generally shaped by what the market will bear. (Appleby, 10/19)